Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) announced a hearing titled "Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices."

“America remains the leader in developing cutting edge biomedical innovation. Countries around the globe look to the FDA for guidance on facilitating safe and effective treatments and medical devices,” said Chairs Rodgers and Guthrie.

“Given the increased funding provided in the most recent user fee reauthorization, it’s important that we engage regularly with key FDA officials to better understand what’s working well at the FDA and what challenges persist. Continuing to rebuild public trust in government health agencies is critical and will require more transparency from agencies like the FDA.” 

Subcommittee on Health hearing titled "Check Up: Examining FDA Regulation of Drugs, Biologics, and Devices." 

WHAT: A hearing to discuss the Food and Drug Administration’s (FDA) regulation of drugs, biologics, and devices. 

DATE: Wednesday, May 22, 2024

TIME: 10:30 AM ET

LOCATION: 2322 Rayburn House Office Building

WITNESSES:

• Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research (CDER), Food and Drug Administration 
• Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration 
• Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health (CDRH), Food and Drug Administration 

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/. If you have any questions concerning the hearing, please contact Emma Schultheis with the Committee staff at Emma.Schultheis@mail.house.gov. If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov.